No Picture
News

MVPvets Appoints New Board Member and Launches The Academy, Providing Veterans with Virtual Training, Mentorship, and Access to The MedTech Conference

SAN DIEGO, July 28, 2020 /PRNewswire/ — MVPvets, a 501(c)(3) nonprofit organization that assists and prepares transitioning military veterans for meaningful employment in medical device and life science companies, announced the appointment of board… […]

No Picture
News

Phanes Therapeutics reveals a new bispecific antibody technology platform at BIO Digital 2020

SAN DIEGO, June 16, 2020 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that it has developed a proprietary bispecific antibody technology platform, PACbodyT… […]

No Picture
News

Neurocrine Biosciences to Present at the Bank of America Securities 2020 Napa Biopharma Conference

Live Webcast will be on June 22, 2020

SAN DIEGO, June 15, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Securities 2020 Napa Biopharma Conference at 2:00 p.m. PT (5:00 p.m. ET) on Monday, June 22… […]

No Picture
News

Neurocrine Biosciences Reports Positive Phase II Data for Crinecerfont in Adults with Congenital Adrenal Hyperplasia at ENDO Online 2020

– Crinecerfont Demonstrates Meaningful Reductions in Key Disease Biomarkers After 14 Days of Treatment- Initiation of Global Registrational Study of Crinecerfont in Adults Planned for Second Half 2020

SAN DIEGO, June 8, 2020 /PRNewswire/ — Neur… […]

No Picture
News

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2020 American Association for Cancer Research Virtual Annual Meeting II

SAN DIEGO, June 1, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced that two posters updating r… […]

No Picture
News

Neurelis Announces Total Of Nine Poster Presentations For The AANN, AMCP, And AAN Annual Meetings

– Data supports pharmacokinetic and safety profile for Neurelis’ lead product, VALTOCO® (diazepam nasal spray), the first and only nasal spray treatment for seizure cluster rescue in pediatric patients 6 years of age and older, adolescents, and adults-… […]

No Picture
News

Mirati Therapeutics To Present Preclinical Data From Investigational Pipeline Of Novel Therapeutics At 2020 American Association For Cancer Research Virtual Annual Meeting II

SAN DIEGO, May 15, 2020 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced it will present preclinical data on the Company’s pipeline of novel therapeutics in three presentations at … […]

No Picture
News

Vividion Therapeutics to Present Data on Novel Covalent E3 Ligase Engager Supporting Broad Targeted Protein Degradation at 2020 AACR Annual Meeting

First Reported E3 Ligase Beyond Cereblon and VHL Shown to Support Broad Targeted Protein Degradation of Multiple Targets In Vivo

SAN DIEGO, May 15, 2020 /PRNewswire/ — Vividion Therapeutics, a biotechnology company discovering and developing highly … […]

No Picture
News

Neurocrine Biosciences to Present at the RBC Capital Markets 2020 Global Healthcare Conference

Live Webcast will be on May 19, 2020

SAN DIEGO, May 14, 2020 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the RBC Capital Markets 2020 Global Healthcare Conference at 3:40 p.m. ET on Tuesday, May 19, 2020. Kevin Gorman,… […]

No Picture
News

Helsinn and MEI Pharma Announce Updated Clinical Data from the Phase 2 Study Evaluating Pracinostat in Combination with Azacitidine in Patients with High/Very-high Risk Myelodysplastic Syndromes

– Data to be Featured in the American Society of Clinical Oncology Annual 2020 Virtual Scientific Program on May 29, 2020 at 8:00 a.m. EDT –

LUGANO, Switzerland and SAN DIEGO, May 13, 2020 /PRNewswire/ — Helsinn Group, a Swiss pharmaceutical group f… […]

No Picture
News

MEI Pharma and Kyowa Kirin Announce Updated Clinical Data from the Phase 1b Study Evaluating ME-401 on an Intermittent Schedule in Patients with Follicular Lymphoma and Other B-cell Malignancies; Data to be Featured in the American Society of Clinical Oncology 2020 Virtual Scientific Program

– 83% overall response rate in patients with relapsed or refractory follicular lymphoma — Median duration of response in follicular lymphoma patients not reached across all patient subsets analyzed — Remains generally well-tolerated with 7% discont… […]

No Picture
News

Neurocrine Biosciences to Present at Bank of America Merrill Lynch Health Care Conference 2020

Live Audio Webcast will be on May 12, 2020

SAN DIEGO, May 5, 2020 /PRNewswire/ –?Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Bank of America Merrill Lynch Health Care Conference 2020 at 2:20 p.m. ET on Tuesday, May 12, 2020. Kevi… […]